Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Quercetin enhances apoptotic effect of tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer‐binding protein homologous protein (CHOP)‐death receptor 5 pathway

View through CrossRef
Although tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) has shown efficacy in a phase 2 clinical trial, development of resistance to TRAIL by tumor cells is a major roadblock. We investigated whether quercetin, a flavonoid, can sensitize human ovarian cancer cells to TRAIL. Results indicate that quercetin sensitized cancer cells to TRAIL. The quercetin induced expression of death receptor DR5 but did not affect expression of DR4 in cancer cells. The induction of DR5 was mediated through activation of JNK and through upregulation of a transcription factor CCAAT enhancer‐binding protein homologous protein (CHOP); as silencing of these signaling molecules abrogated the effect of quercetin. Upregulation of DR5 was mediated through the generation of reactive oxygen species (ROS), as ROS scavengers reduced the effect of quercetin on JNK activation, CHOP upregulation, DR induction, TRAIL sensitization, downregulated the expression of cell survival proteins and upregulated the proapoptotic proteins. Furthermore, quercetin enhances TRAIL mediated inhibition of tumor growth of human SKOV‐3 xenograft was associated with induction of apoptosis, activation of caspase‐3, CHOP and DR5. Overall, our data suggest that quercetin enhances apoptotic death of ovarian cancer cells to TRAIL through upregulation of CHOP‐induced DR5 expression following ROS mediated endoplasmic reticulum‐stress.
Title: Quercetin enhances apoptotic effect of tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer‐binding protein homologous protein (CHOP)‐death receptor 5 pathway
Description:
Although tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) has shown efficacy in a phase 2 clinical trial, development of resistance to TRAIL by tumor cells is a major roadblock.
We investigated whether quercetin, a flavonoid, can sensitize human ovarian cancer cells to TRAIL.
Results indicate that quercetin sensitized cancer cells to TRAIL.
The quercetin induced expression of death receptor DR5 but did not affect expression of DR4 in cancer cells.
The induction of DR5 was mediated through activation of JNK and through upregulation of a transcription factor CCAAT enhancer‐binding protein homologous protein (CHOP); as silencing of these signaling molecules abrogated the effect of quercetin.
Upregulation of DR5 was mediated through the generation of reactive oxygen species (ROS), as ROS scavengers reduced the effect of quercetin on JNK activation, CHOP upregulation, DR induction, TRAIL sensitization, downregulated the expression of cell survival proteins and upregulated the proapoptotic proteins.
Furthermore, quercetin enhances TRAIL mediated inhibition of tumor growth of human SKOV‐3 xenograft was associated with induction of apoptosis, activation of caspase‐3, CHOP and DR5.
Overall, our data suggest that quercetin enhances apoptotic death of ovarian cancer cells to TRAIL through upregulation of CHOP‐induced DR5 expression following ROS mediated endoplasmic reticulum‐stress.

Related Results

Abstract 1294: Sensitization of malignant melanomas to TRAIL-induced apoptosis by quercetin
Abstract 1294: Sensitization of malignant melanomas to TRAIL-induced apoptosis by quercetin
Abstract Skin cancer is among the most commonly-diagnosed cancers with malignant melanoma being associated with the highest rate of metastasis and mortality. In its ...
Abstract 4395: Strategy to overcome inherent TRAIL-based therapeutic limitations
Abstract 4395: Strategy to overcome inherent TRAIL-based therapeutic limitations
Abstract TNF-related apoptosis-inducing ligand (TRAIL) is a promising anti-cancer agent because of its selective ability to induce apoptosis in activated immune cell...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Immune Response to Influenza Virus Infection in Mice
Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Immune Response to Influenza Virus Infection in Mice
ABSTRACTTumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis of various tumor cells but not normal cells. However, various cytokines and virus infectio...
Transmembrane cell signaling by targeted ultrasound contrast agents in cancer therapy
Transmembrane cell signaling by targeted ultrasound contrast agents in cancer therapy
In 2016, over 1.68 million people in the United States are expected to be diagnosed with cancer, with approximately 35% of these cases resulting in death making cancer the second m...
Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3 dependent invasion in resistant non-small cell lung cancer cells
Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3 dependent invasion in resistant non-small cell lung cancer cells
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) triggers apoptosis selectively in tumor cells through interaction with TRAIL-R1/DR4 or TRAIL-R2/DR5 and is con...
Abstract 1261: TRAIL-induced pro- and antiapoptotic kinase activation in non-small cell lung cancer cells
Abstract 1261: TRAIL-induced pro- and antiapoptotic kinase activation in non-small cell lung cancer cells
Abstract Non-small cell lung cancer (NSCLC) is a disease with poor prognosis and novel therapeutic approaches are greatly needed. Tumor necrosis factor (TNF)-related...
Abstract 1941: TRAIL-induced kinase activation in Non small cell lung cancer cells
Abstract 1941: TRAIL-induced kinase activation in Non small cell lung cancer cells
Abstract Non-small cell lung cancer (NSCLC) is a disease with poor prognosis and novel therapeutic approaches are greatly needed. Tumor necrosis factor (TNF)-related...

Back to Top